The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertensionFrank Erhard Uschner, Jonel Trebicka, Mihael Vucur et al.|Oncotarget|2018Cited by 32
Crucial role of beta-arrestin-2 in linking fibrogenesis and cancerRobert Schierwagen, Jonel Trebicka, Peter Dietrich et al.|Journal of Hepatology|2020Cited by 0
THU-055 Differential impact of proton pump inhibitors, statins, and nonselective beta-blockers on survival in different stages of chronic liver diseaseWen Gu, Jonel Trebicka, Dávid Tornai et al.|Journal of Hepatology|2024Cited by 0
WED-111 Plasma proteomics uncovers progression markers of acute-onchronic liver failureFlorian A. Rosenberger, Matthias Mann, Peter V. Treit et al.|Journal of Hepatology|2024Cited by 0
OS-050-YI A genome-wide association study identifies SUSD1 as a risk locus for renal impairment in decompensated cirrhosisLukas Otero Sanchez, P. Martin Padilla, Joan Clãria et al.|Journal of Hepatology|2026Cited by 0